New pill shows promise for lung scarring disease in early trial
NCT ID NCT05938920
First seen Jan 04, 2026 · Last updated May 01, 2026 · Updated 22 times
Summary
This study tested an experimental oral drug called INS018_055 in 71 adults with idiopathic pulmonary fibrosis (IPF), a condition that causes lung scarring and breathing difficulty. The main goal was to check the drug's safety and tolerability over 12 weeks compared to a placebo. Researchers also measured changes in lung function, specifically forced vital capacity (FVC), to see if the drug might help slow disease progression.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS (IPF) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Anhui Chest Hospital
Hefei, Anhui, 230031, China
-
Beijing Friendship Hospital, Capital Medical University
Beijing, Beijing Municipality, 100050, China
-
General Hospital of Tianjin Medical University
Tianjin, Tianjin Municipality, 300052, China
-
Hainan General Hospital
Haikou, Hainan, 570311, China
-
Jiangxi Provincial People's Hospital
Nanchang, Jiangxi, 330006, China
-
Nanfang Hospital of Southern Medical University
Guangzhou, Guangdong, 510515, China
-
Nanjing Drum Tower Hospital
Nanjing, Jiangsu, 210008, China
-
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, 100730, China
-
Peking University Shougang Hospital
Beijing, Beijing Municipality, 100041, China
-
Qilu Hospital of Shandong University
Jinan, Shandong, 250013, China
-
Shanghai Chest Hospital
Shanghai, Shanghai Municipality, 200030, China
-
Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality, 201800, China
-
Shanxi Bethune Hospital
Taiyuan, Shanxi, 030032, China
-
The First Affiliated Hospital - Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310006, China
-
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, 450052, China
-
The First Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, 510080, China
-
The Second Affiliated Hospital of Anhui Medical University
Hefei, Anhui, 230601, China
-
The Second Xiangya Hospital of Central South University
Changsha, Hunan, 410011, China
-
The Shengjing Hospital of China medical university
Shenyang, Liaoning, 110004, China
-
The West China Hospital of Sichuan University
Chengdu, Sichuan, 610041, China
-
Xiangya Hospital of Central South University
Changsha, Hunan, 410008, China
-
Zhongshan hospital Fudan University
Shanghai, Shanghai Municipality, 200032, China
Conditions
Explore the condition pages connected to this study.